NASDAQ · MGX

Metagenomi Therapeutics, Inc.

Closing price · Nov 13, 2026 $0.6917
Last insider buy price $1.18 Paid by Director Laurence Reid on Sep 9, 2026 (Form 4). Not today's price.

Latest quarter · ended Sep 30, 2026

Sales slipped and cash got weaker

descriptionFiled Nov 10, 2026
Revenue growthShrinking
−74.8%
Quarter ended Dec 31, 2024: −22.5% sales vs. a year beforeQuarter ended Mar 31, 2025: −63.0% sales vs. a year beforeQuarter ended Jun 30, 2025: −57.5% sales vs. a year beforeQuarter ended Sep 30, 2025: −24.8% sales vs. a year beforeQuarter ended Dec 31, 2025: −59.3% sales vs. a year beforeQuarter ended Mar 31, 2026: −69.8% sales vs. a year beforeQuarter ended Sep 30, 2026: −74.8% sales vs. a year before
Dec '24Sep '26
$2.18M vs. $8.66M a year ago
Cash from operationsBetter
−$19.1M
Quarter ended Dec 31, 2024: −$26.3M cash from operationsQuarter ended Mar 31, 2025: −$22.8M cash from operationsQuarter ended Jun 30, 2025: −$21.3M cash from operationsQuarter ended Sep 30, 2025: −$21.3M cash from operationsQuarter ended Dec 31, 2025: −$23.5M cash from operationsQuarter ended Mar 31, 2026: −$21.2M cash from operationsQuarter ended Jun 30, 2026: −$19.5M cash from operationsQuarter ended Sep 30, 2026: −$19.1M cash from operations
Dec '24Sep '26
vs. −$21.3M a year ago
Share countSteady
37.81M
Quarter ended Dec 31, 2024: 37.38M sharesQuarter ended Mar 31, 2025: 37.38M sharesQuarter ended Jun 30, 2025: 37.53M sharesQuarter ended Sep 30, 2025: 0 sharesQuarter ended Dec 31, 2025: 37.62M sharesQuarter ended Mar 31, 2026: 37.65M sharesQuarter ended Jun 30, 2026: 37.78M sharesQuarter ended Sep 30, 2026: 37.81M shares
Dec '24Sep '26

Numbers come from the company's own 10-Q and 10-K reports filed with the SEC. Each bar is one quarter, oldest on the left. The colored bar is the latest. Hover over or tap a bar to see its number.

Smart money pulse

What insiders and funds are doing

Selling Insiders: as of Nov 13 Funds: as of Jun 30, 2026
−1000+100 −50
  • info
    13 real insider sales in 12 months. $33.1K in total, not counting planned sales.

−100 means everyone selling, +100 everyone buying. This is data, not advice.

How the Pulse works

Pulse runs from −100 (everyone selling) to +100 (everyone buying). Half comes from insiders: real buyers vs. real sellers in the last 90 days (Form 4). Half comes from funds: funds that bought vs. funds that sold last quarter (13F). 13F is a snapshot of long positions on the last day of the quarter, filed up to 45 days later. It does not show short positions or trades since then.

Who owns it

43 funds report owning MGX, down from 47

Holdings as of Jun 30, 2026
New5
Added8
Held19
Trimmed11
Sold out9

Insider trades · last 12 months

Real buys and sales

● Open-market buy● Open-market sale
CEOCFOOther officersDirectorsDecJanFebMarAprMayJunJulAugSepOctNovStock grant · Dec 1 · $398KStock grant · Dec 1 · $192KStock grant · Dec 1 · $154KGift · Dec 5 · 228,462 shStock grant · Apr 1 · 57,000 sh · 2 peopleStock grant · Apr 1 · 24,000 shOpen-market sale · Dec 5 · $2.84KOpen-market sale · Dec 5 · $6.78KOpen-market sale · Dec 5 · $2.79KOpen-market sale · Dec 5 · $352Open-market sale · Mar 5 · $2.57KOpen-market sale · Mar 5 · $2.53KOpen-market sale · Mar 5 · $771Open-market sale · Jun 5 · $5.58K · 2 peopleOpen-market sale · Jun 5 · $3.75KOpen-market sale · Sep 8 · $2.9K · 2 peopleOpen-market sale · Sep 8 · $2.22KOpen-market buy · Sep 9 · $23.4K
CEOCFOOther officersDirectorsJunJulAugSepOctNovOpen-market sale · Jun 5 · $5.58K · 2 peopleOpen-market sale · Jun 5 · $3.75KOpen-market sale · Sep 8 · $2.9K · 2 peopleOpen-market sale · Sep 8 · $2.22KOpen-market buy · Sep 9 · $23.4K

Last 6 months. A wider screen shows 12.

Showing 14 real trades. Hidden: 6 stock grants, 1 gift. Those happen on a schedule and say little about what an insider thinks. Bigger dot means a bigger trade.

Real trades, newest first

Sep 9 Laurence Reid Director Open-market buy $23.4K 20,000 sh at $1.17
Sep 8 Jian Irish Officer, Director Open-market sale $2.48K 2,140 sh at $1.16 Sold 1% of stake
Sep 8 Pamela Wapnick CFO Open-market sale $2.22K 1,911 sh at $1.16 Sold 1% of stake
Sep 8 Matthew Wein Officer Open-market sale $415 358 sh at $1.16 Sold 1% of stake
Jun 5 Jian Irish Officer, Director Open-market sale $4.86K 3,737 sh at $1.30 Sold 1% of stake
Jun 5 Pamela Wapnick CFO Open-market sale $3.75K 2,884 sh at $1.30 Sold 1% of stake
Jun 5 Matthew Wein Officer Open-market sale $725 558 sh at $1.30 Sold 1% of stake
Mar 5 Jian Irish CEO, Director Open-market sale $2.57K 1,607 sh at $1.60 Sold 1% of stake
Mar 5 Pamela Wapnick CFO Open-market sale $2.53K 1,581 sh at $1.60 Sold 1% of stake
Mar 5 Matthew Wein Officer Open-market sale $771 482 sh at $1.60 Sold 1% of stake
Show 4 older real trades
Dec 5 Brian Thomas Director Open-market sale $6.78K 3,830 sh at $1.77 Sold 1% of stake
Dec 5 Jian Irish CEO, Director Open-market sale $2.84K 1,602 sh at $1.77 Sold 1% of stake
Dec 5 Pamela Wapnick CFO Open-market sale $2.79K 1,576 sh at $1.77 Sold 1% of stake
Dec 5 Matthew Wein Officer Open-market sale $352 199 sh at $1.77 Sold 1% of stake

Showing every filing. Dashed circles are routine: grants, tax withholding, option exercises and planned sales.

Top holders

Biggest funds in MGX

As of Jun 30, 2026
FundOwnsValueChange
Vanguard Capital Management LLC2.9%$1.28M+2%
Renaissance Technologies LLC2.0%$883K−6%
Catalio Capital Management, LP1.4%$630KSame
Peapod Lane Capital LLC1.4%$625K+2%
Two Sigma Investments, LP1.4%$611K+3%

"Owns" is shares reported divided by shares outstanding.

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast · Your watchlist